{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:11025495",
      "entity_text" : "cholesterol",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-1172" ]
    }
  },
  "verbose_text" : "The very first rigorous proof of the lipid hypothesis (ie, lowering the level of cholesterol, a previously known atherosclerotic risk factor, reduces risk for future development of hard clinical cardiovascular morbid events) in man was published over 25 years ago, comparing the use of the bile acid sequestrant (BAS) cholestyramine with placebo in over 3800 patients with hypercholesterolemia who were all partaking in a moderately low cholesterol diet.",
  "reading_complete" : "2020-08-05T22:40:30Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T22:34:46Z",
  "trigger" : "level",
  "evidence" : [ "level of cholesterol" ],
  "pmc_id" : "3426253",
  "score" : 0
}